About
Delphistem develops a stem cell-based therapy to restore natural insulin production in people with diabetes through a non-invasive, scalable, and cost-effective approach.
Explore Delphistem's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.